Medical Products Supplies Companies

Lumbyvej 19G, 5000 Odense C
Denmark
Telephone +45 3696 9496
support@pentabase.com
http://pentabase.com

Product Categories

Product categories

03 Diagnostic Tests
03.06 Genetic testing, molecular diagnostics
03.06.02 Molecular biomarkers

Molecular biomarkers

Our products

Product category: Molecular biomarkers
SensiScreen® Cancer IVD Assays
CE IVD Cancer Companion Diagnostics
SensiScreen® CE IVD are real-time PCR based assays for somatic mutation detection in cancer patients. SensiScreen® assays combine ultra high sensitivity with multiplexing capabilities, speed, ease-of-use and little hands-on-time. Important features of SensiScreen® assays are the implementation of PentaBase’s proprietary DNA analogue platform technology and the inclusion of baseblockers that make SensiScreen® assays superior to most current somatic mutation tests with regard to sensitivity and specificity.

Product category: Molecular biomarkers
PlentiPlex™ Mastocytosis, MSI and MYD88 IVD Assays
PlentiPlex™ is a series of ready-to-use PCR-based assays for convenient and accurate analysis of DNA including genotyping, microsatellite instability and somatic mutation detection. Common for PlentiPlex™ assays is that they rely on PentaBase’s INA® platform technologies; SuPrimers™, EasyBeacons™, HydrolEasy™ probes and BaseBlockers™, to assure ease-of-use, robustness and straightforward data analysis.

PlentiPlex™ assays include PlentiPlex™ Mastocytosis for highly sensitive and selective detection of KIT D816V mutations in mast cells, PlentiPlex™ MSI for easy and fully multiplexed determination of microsatellite instability and PlentiPlex™ MYD88 for assisting the diagnosis of lymphoma.

Product category: Molecular biomarkers
MyGo Mini Real-Time PCR
Personal precision
With no moving parts it provides silent operation and maximum reliability. It provides users with great results over a broad range of applications.

Easy Analysis
Easy-to-use software and robust, high performance algorithms which provide accurate results from complex data.

Solid-state reliability
The MyGo Mini is the world´s first completely solid-state real-time PCR machine, with no moving parts.

Compatibility
The MyGo software can be installed on Mac OS X, Windows, and Linux OS. It is also compatible with standard o0, mL low-profile tubes, which are convenient and cost-effective.

Connectivity
A dedicated computer is not required. You can run the OS that you are familiar with. It also enables to control hundreds of instruments whilst simultaneously analysing run data on one computer.

Product category: Molecular biomarkers
MyGo Pro Real-Time PCR
Real-Time PCR thermocycler with full spectrum optics which deliver 120 optical channels of fluorescence data from every tube.

High performance Peltier elements, combined with solid silver blocks, provide both speed and proven world-leading thermal uniformity.

Precision and performance
Users can now address biological phenomena with subtle effects on gene expression, or pathogen levels, for example discriminating 10% differences in transcript concentrations. The system can discriminate all classes of SNP, including Class 4 SNPs via HRM.

Multiplex with full spectrum optics
Full spectrum optics (120 channels) combined with advanced matrix deconvolution technology enable simultaneous analysis of at least 7 different targets in a single reaction, each monitored with a different colour of fluorescent label.

Easy analysis
The MyGo Pro system comes with easy-to-use SW, and robust high performance algorithms provide accurate results from complex data.<reliability

A very few moving part made this instrument high reliable which comes with the option of a 5 year extended warranty.

Speed
With heating rates of 5°C per second and cooling rates of 4°C per second the MyGo Pro is one of the fastest systems available. The system demonstrates excellent quantitative precision and speed, with 45 cycles of PCR in 33 minutes.

ad: contact information

About Us

Company details
Mission and Visions
Mission:

Our mission is, based on our knowledge and proprietary DNA platform technologies, to offer scientists and researchers better and more precise tools for genetical analyses.

Our visions are:

To enable detection and monitoring of treatable diseases as early and as efficiently as possible.
To broaden and improve the use of personalized treatment of genetic diseases and cancer.
To reduce the number of false negative samples by improving sensitivity and reducing complexity of genetic analyses.

ad: company